Amedisys Reports Third Quarter 2020 Financial Results - Updates 2020 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Amedisys (AMED) Tops Q3 EPS by 96c
October 28, 2020 4:06 PM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $2.24, $0.96 better than the analyst estimate of $1.28. Revenue for the quarter came in at $544.1 million versus the consensus estimate of $533.18 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our third quarter results which have bested both our internal and external... More
